The purpose of the present study was to test the hypothesis that ATP-sensitive potassium channels mediate autoregulatory vasodilatation of coronary arterioles in vivo. Experiments were performed in 23 open-chest anesthetized dogs. Coronary arterial microvascular diameters were directly measured with fluorescence microangiography using an intravital microscope and stroboscopic epi-illumination synchronized to the cardiac cycle. A mild coronary stenosis (perfusion pres-sure=60 mm Hg), a critical coronary stenosis (perfusion pressure=40 mm Hg), and complete coronary artery occlusion were produced with an occluder around the left anterior descending coronary artery in the presence or absence of glibenclamide (10-`M, topically), which inhibits ATP-sensitive potassium channels, or of vehicle. During topical application of vehicle (0.01% dimethyl sulfoxide), there was dilatation of small (<100 gm diameter) arterioles during reductions in perfusion pressure (percent change in diameter. 6.7±1.5%, 11.7±3.5%, and 10.4±5.1% during mild stenosis, critical stenosis, and complete occlusion, respectively). In the presence of glibenclamide, arteriolar dilatations during coronary stenoses and occlusions were abolished. Glibenclamide did not affect responses of arterioles >100 ,um. Glibenclamide did not alter microvascular responses to nitroprusside. These data suggest that ATP-sensitive potassium channels play an important role in determining the coronary microvascular response to reductions in perfusion pressure. (Circulation Research 1991;69:1146-1151 T he coronary arterial system autoregulates effectively during reductions in perfusion pressure.1'2 Kanatsuka et a13 and Chilian and Layne4 independently demonstrated dilatation of small coronary arterioles during hypotension. Acute occlusion of a coronary artery also produced dilatation of small arterioles.5
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The purpose of the present study was to test the hypothesis that ATP-sensitive potassium channels mediate autoregulatory vasodilatation of coronary arterioles in vivo. Experiments were performed in 23 open-chest anesthetized dogs. Coronary arterial microvascular diameters were directly measured with fluorescence microangiography using an intravital microscope and stroboscopic epi-illumination synchronized to the cardiac cycle. A mild coronary stenosis (perfusion pres-sure=60 mm Hg), a critical coronary stenosis (perfusion pressure=40 mm Hg), and complete coronary artery occlusion were produced with an occluder around the left anterior descending coronary artery in the presence or absence of glibenclamide (10-`M, topically), which inhibits ATP-sensitive potassium channels, or of vehicle. During topical application of vehicle (0.01% dimethyl sulfoxide), there was dilatation of small (<100 gm diameter) arterioles during reductions in perfusion pressure (percent change in diameter. 6 .7±1.5%, 11.7±3.5%, and 10.4±5.1% during mild stenosis, critical stenosis, and complete occlusion, respectively). In the presence of glibenclamide, arteriolar dilatations during coronary stenoses and occlusions were abolished. Glibenclamide did not affect responses of arterioles >100 ,um. Glibenclamide did not alter microvascular responses to nitroprusside. These data suggest that ATP-sensitive potassium channels play an important role in determining the coronary microvascular response to reductions in perfusion pressure. (Circulation Research 1991; 69:1146 -1151 T he coronary arterial system autoregulates effectively during reductions in perfusion pressure.1'2 Kanatsuka et a13 and Chilian and Layne4 independently demonstrated dilatation of small coronary arterioles during hypotension. Acute occlusion of a coronary artery also produced dilatation of small arterioles. 5 Since Noma6 described an ATP-sensitive potassium channel in the cardiac myocyte, this channel has been identified in pancreatic p3 cells,7 skeletal muscle,8 the central nervous system,9 and vascular smooth muscle.10 The opening of this channel is linked to cellular metabolism as the probability of its opening increases with deceases in intracellular ATP levels. Furthermore, it is possible that other nucleotides, change in pH, and other metabolic factors including adenosine may modulate the opening of this channel.11'2 Opening of ATP-sensitive potassium channels consequently causes hyperpolarization of tissues because of K+ efflux.1112 Hyperpolarization in vascular smooth muscle inhibits the Ca2+ influx via voltage-dependent Ca2+ channels and leads to vasodilatation. Recently, Daut et al13 have described a role for the ATP-sensitive potassium channels in hypoxia-induced coronary vasodilatation in the excised heart. The participation of these channels in coronary microvascular autoregulatory response in vivo has not been determined.
The purpose of this study was to test the hypothesis that activation of ATP-sensitive potassium channels mediates autoregulatory vasodilatation of coronary microvessels. We observed the effect of glibenclamide, a potent and selective inhibitor of ATP-sensitive potassium channels,'4 on the arteriolar response during autoregulation and ischemia by means of direct observation of coronary microvessels in an intact beating left ventricle.
Materials and Methods

General Preparation
Mongrel dogs of either sex (n=23, body weight of 6.5+0.3 kg) were sedated with ketamine (10 mg/kg i.m.) and acepromazine (0.2 mg/kg) and anesthetized with a-chloralose (75 mg/kg i.v.). Additional doses of a-chloralose were given as needed to maintain a surgical depth of anesthesia. A catheter (1.7 mm o.d.) was inserted into the descending thoracic aorta through the femoral artery for measurement of aortic pressure and withdrawal of arterial blood for measurement of myocardial perfusion by the radioactive microsphere technique. Another catheter (1.7 mm o.d.) was inserted into the femoral vein for infusion of fluids.
A cuffed endotracheal tube was inserted into the trachea. To minimize respiration-induced cardiac motion, high-frequency jet ventilation synchronized to cardiac cycles was used, as previously described in detail. 3, 5, 15, 16 Positive end-expiratory pressure was applied to prevent atelectasis.
A left thoracotomy was performed in the fifth intercostal space, and the heart was suspended in a pericardial cradle. A catheter was inserted into the left atrium through the left appendage for administration of fluorescent dye and radiolabeled microspheres. A 5F catheter (Millar Instruments, Inc., Houston, Tex.) was inserted into the left ventricle through the left atrial appendage for measurement of left ventricular pressure and dP/dt. Heart rate was kept constant during the experiment by left atrial pacing (152+1 beats/min) after suppression of sinus node activity with injection of 7% formaldehyde into the region of the sinus node. Snares were placed around the descending aorta and the inferior vena cava to maintain systemic pressure at control levels during the experiment. The left anterior descending coronary artery (LAD) was carefully dissected, and a screw occluder was placed around the vessel to produce reductions in perfusion pressure. A 24-gauge catheter was inserted into a distal branch of the LAD to monitor distal coronary arterial pressure. The surface of the heart was kept moist by dripping warmed Krebs' solution containing (mM) NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4 1.2, NaHCO3 25.0, and KH2P04 1.2 bubbled with 20% 02, 5% C02, and 75% N2 at the rate of 2 ml/min. Body temperature was maintained with a servocontrolled thermal blanket.
Microscope and Video System
For direct observation of the coronary microvessels in the beating left ventricle, we used an intravital microscope (Zeiss, FRG) equipped with a computerized strobe (Chadwick Helmuth, El Monte, Calif.), which epi-illuminated the cardiac surface at a single point in mid diastole during each cardiac cycle. Details have been described previously.35,15"56 With this system, fluorescence coronary microangiography was performed. Fluorescein isothiocyanate-dextran (molecular weight 487,000, Sigma Chemical Co., St. Louis, Mo.) was injected into the left atrium as a constrast medium. A x6.3 objective (n.a. 0.2, Zeiss) was used.
Microvascular fluorescent images were transmitted to a silicon-intensified tube video camera (General Electric, Owensboro, Ky.) via x 1 or x 6.3 relay lens monitor (Panasonic, Japan). Spatial resolution was 8 ,um (x 1 relay lens) or 5 ,um (x 6.3 relay lens). Edges of the enhanced arterioles were traced with a digitizing tablet (Summa Graphics, Cambridge, Mass.), and their internal diameters were calculated. When arterioles < 100 ,um were observed, we used a x 6.3 relay lens. Each vessel was measured three times using different images of the same vessel.
Measurement of Myocardial Blood Flow
Myocardial blood flow was measured with the radioactive microsphere technique, as previously reported.3'5"5"16 Reference blood was collected from the femoral artery at the rate of 1.91 ml/min with a Harvard pump (Dover, Mass.). At the end of the experiment, the heart was excised, and tissue samples were cut from the ischemic area (LAD perfusion area). Radioactivity of tissue samples and reference samples was counted with a germanium crystal gamma counter17 (Canberra Industries Inc., Meriden, Conn.), and myocardial blood flow (MBF, ml/min/100 g) was calculated using the following equation:
MBF=(CmxWRx 100)/Cr where Cm is radioactivity per weight (g) of tissues, WR is withdrawal rate of the reference blood sample (ml/min), and Cr is total radioactivity of the reference blood sample.
Protocols
After the surgical procedure and instrumentation, at least 30 minutes was allowed for stabilization of the monitored variables. Microvessels for observation were selected in the region of cyanosis produced by a brief coronary occlusion. In 11 dogs, after control measurements of hemodynamics, microvascular diameter, and myocardial perfusion, glibenclamide (final concentration, 10-5 M) was superfused onto the surface of the heart via a side port into the suffusion solution and continued until the end of the experiment (glibenclamide group). Glibenclamide potassium salt (The Upjohn Co., Kalamazoo, Mich.) was dissolved in Krebs' solution containing dimethyl sulfoxide (final concentration, 0.01 vol%). Twenty minutes after superfusion of glibenclamide, the LAD screw occluder was tightened to sequentially reduce perfusion pressure to 60 mm Hg (mild stenosis), 40 mm Hg (severe stenosis), and a complete occlusion. Complete occlusion usually caused mild systemic hypotension. Arterial pressure was returned to control levels by tightening the aortic snare. After stabilization at each level of stenosis (minimum of 10 minutes), microvascular images, hemodynamics, and myocardial perfusion were measured. One dog died of ventricular fibrillation during complete occlusion.
In another 12 dogs, the effect of vehicle was tested (vehicle group). The experimental procedures and protocol were the same as above except that vehicle (0.01% dimethyl sulfoxide solution) was superfused instead of glibenclamide. In the vehicle group, one dog and were digitized and displayed on a high resolution died of ventricular fibrillation during the critical stenosis, and three dogs died during complete occlusion.
At the end of the experiment, Evans blue dye (1.25%) was injected through the distal coronary catheter to stain the ischemic region. Observed microvessels were located at least 5 mm within the border of the ischemic area.
In an additional three dogs, the effect of glibenclamide on nitroprusside-induced vasodilatation was evaluated to exclude a nonspecific inhibitory effect of glibenclamide on smooth muscle relaxation in arterioles. Nitroprusside (10-`M, Sigma Chemical) was superfused in the absence and presence of glibenclamide (10-5 M) . Changes in diameters produced by nitroprusside were measured after 10 minutes.
Statistical Analysis
All values are presented as mean±SEM. Leastsquares regression analysis (polynomial) was performed to investigate the relation between control arteriolar diameter and vascular response. Arterioles were divided into two groups according to control sizes, small arterioles (<100 ,um) and large arterioles (>100 ,gm). One-way analysis ofvariance was used to evaluate the changes in hemodynamic variables, regional coronary blood flow, blood gases, and microvascular diameters. Student's t test for paired samples or nonpaired samples with Bonferroni correction was used for individual comparisons. Differences were considered significant atp<0.05.
Results
Hemodynamics and Blood Gases
In the vehicle group, systolic, diastolic, and mean aortic pressures during control conditions were 105+4, 79+5, and 91±5 mm Hg, respectively. In the glibenclamide group, these values were 111+4, 87+4, and 97+4 mm Hg, respectively. In both groups, aortic pressure was constant during the experiments. Po2, PCO2, and pH were maintained within the physiological range during the experiments (Table 1) .
Transmural coronary blood flow and coronary perfusion pressure during each level of stenosis are shown in Table 1 . There were no differences in coronary perfusion pressure between the glibenclamide and vehicle groups during each experimental condition ( Table 1) . Transmural coronary flow during a mild stenosis was not significantly different from control. Coronary flow was significantly reduced by a critical stenosis and complete occlusion.
Microvascular Response
Control microvascular diameters were not significantly different between vehicle and glibenclamide groups in either small or large arterioles. Vehicle itself did not alter microvascular diameters, as shown in Figure 1A (small arterioles: 68±5 ,um before and 67±5 gm after vehicle, p=NS; large arterioles: 170±18 gm before and 165±19 ,um after vehicle, p=NS). In the vehicle group, small arterioles dilated during a mild stenosis, whereas larger arterioles did not change ( Figure 1B) . During a critical stenosis and complete occlusion, dilatation in small arterioles was observed ( Figures 1C and 1D, respectively) . Large arteriolar diameters decreased during complete occlusion ( Figure 1D ). Degrees of microvascular responses were significantly correlated to control diameters in all three perfusion pressure levels.
Glibenclamide itself did not cause a significant change in microvascular diameters, as shown in Regression analysis shows that microvascular response to reduction of perfusion pressure was significantly related to control diameters (panels B, C, and D). The x axis intercept of regression lines was 146, 139, and 105 um during mild stenosis, critical stenosis, and complete occlusion, respectively. Large arteriolar diameters were not different between the vehicleand glibenclamide-treated groups (Figure 3) .
In another three dogs, the effect of glibenclamide on nitroprusside-induced dilatation was investigated. In large (n=4) or small (n=5) arterioles, the nitroprusside-induced dilatation was not altered by glibenclamide (large arterioles: 9.4+±4.1% before and 16.4±5.8% after glibenclamide, p=NS; small arterioles: 20.9±5.4% before and 25.8±5.7% after glibenclamide, p=NS).
Discussion
The present study provides evidence that ATPsensitive K' channels play an important role in regulating coronary blood flow. Under control conditions, a reduction in perfusion pressure caused small arterioles to dilate. This result is consistent with several previous investigations,3-5 although Chilian and Layne4 reported that larger arterial microvessels also participate in the autoregulatory response. Daut et al'3 suggested that ATP-sensitive K' channels may mediate ischemia-induced vasodilation in the excised heart as well as hypoxia-induced coronary vasodilation. In the present study, glibenclamide abolished arteriolar vasodilations in re-sponse to reduction in perfusion pressure yet did not reduce dilator responses to nitroprusside. Because glibenclamide is a potent and specific inhibitor of ATP-sensitive K' channels,14 the data indicate that ATP-sensitive K' channels mediate the arteriolar responses to reductions in coronary perfusion pressure and suggest that a common mechanism may mediate vasodilation during autoregulation, critical stenosis, and complete occlusion.
Methodological Consideration
To produce the reduction of perfusion pressure, the LAD was dissected, and a snare was placed around it. Implantation of devices around the LAD and surgical treatment is known to impair autonomic tone. 18 Furthermore, a-chloralose, which was used in this study, may also modulate the autonomic tone. However, the autoregulatory response is basically an intrinsic phenomenon that can occur in the absence of extrinsic influences such as neural or humoral factors. Furthermore, the instrumentation and procedures were applied to both vehicle and glibenclamide groups in the same manner. Accordingly, the conclusion drawn in the present study cannot be affected by these factors. during a mild coronary stenosis with glibenclamide (panel B, coronary perfusion pressure=62+2 mm Hg), during a critical coronary stenosis with glibenclamide (panel C, coronary perfusion pressure =41+1 mm Hg), and during a complete coronary occlusion with glibenclamide (panel D, coronary perfusion pressure=28+2 mm Hg). Shaded area, small arterioles; nonshaded area, large arterioles; NS, not significant. Note that small arteriolar (<100 ,um) dilatation in response to reduction in perfusion pressure was blocked by glibenclamide.
In our system, spatial resolution is 5 gm, and the changes in microvascular diameter by reduction in perfusion pressure were greater than the minimal resolution. These microvascular responses to reduction in perfusion pressure were reproducible, since other in-vestigators3'5 have reported the similar results.
Potential Mechanisms for Autoregulatory and Ischemic Vasodilatation in the Coronary Circulation
ATP-sensitive K' channels have been shown to be linked to intracellular ATP levels.'1 The present study suggests that autoregulatory microvascular vasodilatation was mediated, at least in part, by an electrophysiological phenomenon that was modulated by the metabolism of vascular smooth muscle. The ATP level of microvascular smooth muscle during autoregulation has not yet been determined. In ischemic myocardium, the level of ATP does not decrease until later phases of ischemia. 19 However, studies by Jones20 have suggested that intracellular ATP is compartmentalized and that a gradient of intracellular ATP concentration exists from mitochondria to the cell membrane. If this is the case in coronary arteriolar smooth muscle, the ATP concentration in the vicinity of this channel may be low enough to cause opening of these channels.
The ATP-sensitive K' channel is also known to be regulated by receptor-operated mechanisms.14 In insulinoma cells, somatostatin and galanin increase the opening probability of this channel to secrete insulin.14 Recently, Kirsch et a121 have shown that the A,-adenosine receptor is linked to ATP-sensitive potassium channels via Gi protein in the cardiocyte.
Protein kinase C has also been suggested to modulate the opening in insulinoma cells.14 The roles of G protein or protein kinase C in autoregulation or ischemic vascular response in coronary arterial system remain undetermined.
Effect of Glibenclamide on Large Coronary Arterioles
In large arterioles (>100 ,um), glibenclamide did not cause a significant change in vascular response to reductions in perfusion pressure. Diameters of large arterioles remained at control level during a mild and critical stenosis despite reduction in distending pressure, demonstrating there may be some change in vascular tone in large arterioles as well as small ones. However, results by others3-5 suggest that, in autoregulatory vasodilatation, the role of large arterioles is minimal. Therefore, the absence of effect with glibenclamide during decreases in perfusion pressure in large arterioles is not surprising. This observation, however, does not necessarily indicate that ATP- sensitive potassium channels do not exist or function in large arterioles, because passive collapse produced by low perfusion pressure may have masked the vasodilatation via this channel. In summary, glibenclamide significantly attenuated the small coronary arteriolar response to a reduction of perfusion pressure without reducing dilator responses to nitroprusside. These results suggested that ATP-sensitive potassium channels play a crucial role in autoregulatory coronary microvascular dilatation. Further studies are required to determine the mechanisms that modulate ATP-sensitive potassium channels during coronary autoregulation.
